StefanCharlesGrantMD
Oncology • New Orleans, LAAssociate Professor, Medicine, Associate Director Clinical and Translational Research and IP Development, Wake Forest Baptist Comprehensive Cancer Center
Dr. Grant is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1430 Tulane Ave
# 8016
New Orleans, LA 70112Phone+1 504-988-7518Fax+1 504-988-8252
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1988 - 1992
Albert Einstein Healthcare NetworkResidency, Internal Medicine, 1985 - 1988
University of the WitwatersrandClass of 1981
Certifications & Licensure
NY State Medical License 1988 - 2026
LA State Medical License 2023 - 2025
NC State Medical License 2014 - 2024
OH State Medical License 2022 - 2024
AL State Medical License 2011 - 2014
PA State Medical License 1986 - 1990- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Rovalpituzumab Tesirine (SC16LD6.5) in Recurrent Small Cell Lung Cancer Start of enrollment: 2013 Jul 01
- Evaluation of Lucanthone to Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer Start of enrollment: 2016 Jan 01
- Pemetrexed Disodium in Treating Patients With Stage IV Non-small Cell Lung Cancer and ECOG Performance Status 3 Start of enrollment: 2015 May 01
- Join now to see all
Publications & Presentations
PubMed
- 70 citationsThymomas and thymic carcinomasDavid S. Ettinger, Gregory J. Riely, Wallace Akerley, Hossein Borghaei, Andrew C. Chang
Journal of the National Comprehensive Cancer Network. 2013-05-01 - 29 citationsPatient-Reported Outcomes From Patients Receiving Immunotherapy or Chemoimmunotherapy for Metastatic Non-Small-Cell Lung Cancer in Clinical Practice.Laurie E. McLouth, Thomas Lycan, Beverly J. Levine, Jennifer Gabbard, Jimmy Ruiz
Clinical Lung Cancer. 2020-05-01 - 68 citationsEnhancement of Antitumor Immunity in Lung Cancer by Targeting Myeloid-Derived Suppressor Cell PathwaysAnandi Sawant, Cara C. Schafer, Tong Huan Jin, Jaroslaw W. Zmijewski, Hubert M. Tse
Cancer Research. 2013-11-15
Press Mentions
Genetic Alterations in Lung Cancers Help Select TreatmentMay 20th, 2014
74 Oncologists on the MoveOctober 11th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
